Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside.

Archive ouverte

Dorvignit, Denise | García-Martínez, Liliana | Rossin, Aurélie | Sosa, Katya | Viera, Justo | Hernández, Tays | Mateo, Cristina | Hueber, Anne-Odile | Mesa, Circe | López-Requena, Alejandro

Edité par CCSD ; Elsevier -

International audience. Gangliosides are sialic acid-bearing glycosphingolipids expressed on all mammalian cell membranes, and participate in several cellular processes. During malignant transformation their expression changes, both at the quantitative and qualitative levels. Of particular interest is the overexpression by tumor cells of Neu5Gc-gangliosides, which are absent, or detected in trace amounts, in human normal cells. The GM3(Neu5Gc) ganglioside in particular has been detected in many human tumors, and it is considered one of the few tumor specific antigen. We previously demonstrated that a humanized antibody specific for this molecule, named 14F7hT, retained the binding and cytotoxic properties of the mouse antibody. In this work, we confirm that 14F7hT exerts a non-apoptotic cell death mechanism in vitro and shows its potent in vivo antitumor activity on a solid mouse myeloma model. Also, we demonstrate, in contrast to the murine counterpart, the capacity of this antibody to induce antibody-dependent cell-mediated cytotoxicity using human effector cells, which increases its potential for the treatment of GM3(Neu5Gc)-expressing human tumors.

Consulter en ligne

Suggestions

Du même auteur

Antitumor and cytotoxic properties of a humanized antibody specific for the GM3(Neu5Gc) ganglioside

Archive ouverte | Dorvignit, Denise | CCSD

International audience

A rationally-engineered IL-2 improves the antitumor effect of anti-CD20 therapy

Archive ouverte | Casadesús, Ana, Victoria | CCSD

International audience. Anti-CD20 treatment represents a therapeutic benefit for patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relapsing patients. Among them, the com...

Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy

Archive ouverte | Casadesús, Ana Victoria | CCSD

International audience. Introduction The anti-CD20 antibody rituximab (RTX) has substantially improved outcomes of patients with B-cell lymphomas, although more efficient therapies are needed for refractory or relap...

Chargement des enrichissements...